Home/Companies/Biotech/Enyo Pharma

Enyo Pharma

Biotech·

France·Active·8yr hold

Entry

2018

Hold

8yr

Status

Active

Who owns Enyo Pharma?

Enyo Pharma is a French Biotech company, currently owned by Andera Partners since 2018 and 2 other investors.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY

Most recent investor

Andera Partners

BioDiscovery 5 · 2017 · VC

3 ownership periods · full history below

Key facts

HQFrance

SectorBiotech

Websitewww.enyopharma.com

Ownership history

3 ownership periods · co-invest detected

Active

Co-held by Bpifrance Investissement, Sofinnova Partners and Andera Partners since 2016.

Co-invest · 3 holders · 2016 · present

Bpifrance InvestissementActive

2016 · present(10yr) · Large Venture · 2013 · Growth

Sofinnova PartnersActive

2016 · present(10yr) · Sofinnova Capital VIII · 2015 · Life Sciences VC

Andera PartnersActive

2018 · present(8yr) · BioDiscovery 5 · 2017 · VC

More from BioDiscovery 5

Other portfolio companies in the same fund.

to Public market (NYSE IPO ticker EVMN)

to Public market (Nasdaq IPO ticker AGMB)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Questions

Who owns Enyo Pharma?

Enyo Pharma is currently owned by Andera Partners, Bpifrance Investissement and 1 other, through BioDiscovery 5, since 2018.

When did Andera Partners and 2 others acquire Enyo Pharma?

Andera Partners and 2 others acquired Enyo Pharma in 2018.

Who has owned Enyo Pharma over time?

Enyo Pharma has been through 3 private-equity ownership periods: Bpifrance Investissement · via Large Venture · since 2016; Sofinnova Partners · via Sofinnova Capital VIII · since 2016; Andera Partners · via BioDiscovery 5 · since 2018.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue